CINGULATE THERAPEUTICS

Executives
Shane J. Schaffer, PharmD
Chairman, Chief Executive Officer
Raul R. Silva
MD Chief Science Office
Louis G. Van Horn, MBA CPA
Chief Financial Officer
Laurie Myers
PhD, MBA, Chief Operating Officer
Board
Shane J. Schaffer PharmD
Chairman, Chief Executive Officer
Jeff Conroy
Director
Patrick Gallagher MBA, CFA
Director
Jeff Hargroves
Director
Peter J. Werth
Director
Curt Medeiros
Director
Gregg Givens
Director
Contact
Website
www.cingulate.com
Address
1901 W 47th Place Kansas City, KS 66205
Twitter
twitter.com/CingulateInc
Linkdin
www.linkedin.com/company/cingulateinc/?viewAsMember=true

About CINGULATE THERAPEUTICS

Cingulate is a clinical stage biopharmaceutical company focused on the development of innovative new product candidates for the treatments of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety associated disorders.